• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

DEXEBTC:LX

457.20 USD 0.77 0.17%

As of 00:59:30 ET on 09/29/2014.

Snapshot for Candriam Equities L Biotechnology (DEXEBTC)

Year To Date: +21.01% 3-Month: +8.20% 3-Year: +41.48% 52-Week Range: 335.14 - 459.53
1-Month: +0.40% 1-Year: +27.51% 5-Year: +27.12% Beta vs BTK: 0.91

Mutual Fund Chart for DEXEBTC

No chart data available.
  • DEXEBTC:LX 457.20
  • 1M
  • 1Y
Interactive DEXEBTC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DEXEBTC

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: 04-06-2000 Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for DEXEBTC

NAV (on 2014-09-26) 456.43
Assets (M) (on 2014-09-26) 617.06
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DEXEBTC

No dividends reported

Fees & Expenses for DEXEBTC

Front Load 3.50
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.77

Top Fund Holdings for DEXEBTC

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 538,000 49,253,900 8.777%
Celgene Corp 558,000 48,629,700 8.666%
Amgen Inc 353,000 44,968,670 8.013%
Biogen Idec Inc 114,850 38,404,692 6.844%
Alexion Pharmaceuticals Inc 176,500 28,061,735 5.001%
Regeneron Pharmaceuticals Inc 74,500 23,558,390 4.198%
Vertex Pharmaceuticals Inc 206,000 18,315,460 3.264%
Illumina Inc 106,000 16,950,460 3.021%
BioMarin Pharmaceutical Inc 201,000 12,425,820 2.214%
Salix Pharmaceuticals Ltd 87,000 11,476,170 2.045%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil